Oppenheimer Asset Management Inc. lessened its position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD – Free Report) by 23.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 23,055 shares of the company’s stock after selling 7,167 shares during the period. Oppenheimer Asset Management Inc. owned 0.06% of Viemed Healthcare worth $185,000 at the end of the most recent reporting period.
Other institutional investors have also recently added to or reduced their stakes in the company. Rice Hall James & Associates LLC bought a new position in shares of Viemed Healthcare in the 4th quarter worth $2,083,000. Rhumbline Advisers increased its holdings in Viemed Healthcare by 15.5% during the fourth quarter. Rhumbline Advisers now owns 46,836 shares of the company’s stock worth $376,000 after buying an additional 6,275 shares during the last quarter. R Squared Ltd bought a new stake in shares of Viemed Healthcare in the 4th quarter worth approximately $41,000. SG Americas Securities LLC raised its stake in Viemed Healthcare by 193.1% in the 4th quarter. SG Americas Securities LLC now owns 35,579 shares of the company’s stock valued at $285,000 after acquiring an additional 23,442 shares during the period. Finally, JPMorgan Chase & Co. lifted its stake in shares of Viemed Healthcare by 151.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 98,798 shares of the company’s stock valued at $724,000 after buying an additional 59,538 shares in the last quarter. 74.24% of the stock is owned by institutional investors and hedge funds.
Viemed Healthcare Price Performance
Shares of NASDAQ VMD opened at $7.50 on Friday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The stock has a market cap of $292.03 million, a PE ratio of 27.78 and a beta of 1.50. Viemed Healthcare, Inc. has a fifty-two week low of $6.21 and a fifty-two week high of $10.44. The stock has a fifty day moving average of $8.01 and a 200-day moving average of $8.18.
Viemed Healthcare Profile
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Featured Articles
- Five stocks we like better than Viemed Healthcare
- Quiet Period Expirations Explained
- Is Myers Industries Poised for a Breakout?
- What is the Australian Securities Exchange (ASX)
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- Basic Materials Stocks Investing
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Want to see what other hedge funds are holding VMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viemed Healthcare, Inc. (NASDAQ:VMD – Free Report).
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.